#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma recurrent Juvenile chronic myelomonocytic leukaemia Malignant neoplasm of choroid Adrenoleukodystrophy Hereditary angioedema Pancreatic carcinoma metastatic Wiskott-Aldrich syndrome Extra-osseous Ewing's sarcoma metastatic Intracranial calcification Glomerulonephritis acute Oesophageal squamous cell carcinoma stage II Microvillous inclusion disease Duchenne muscular dystrophy Sarcoidosis Eosinophilic granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Treatment Undifferentiated sarcoma – Treatment Usher’s syndrome – Treatment Paraneoplastic neurological syndrome – Treatment Sarcoma – Life with Disease Inclusion body myositis – Life with Disease Retinitis pigmentosa – Trials in Disease Osteosarcoma recurrent Leiomyosarcoma recurrent – Basic Information Haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [14C] DC-806 Fedratinib Ataluren Vinflunine Progesterone Ph. Eur. Topotecan Adrenaline Tartrate Ph. Eur. Nadunolimab RP3 Calcium Pantothenate Bp Gliclazide Clazakizumab Glutenin Soya Oil PEGVISOMANT SECRETIN SYNTHETIC HUMAN Dimeticone Eteplirsen Pemetrexed Diacid Monohydrate Ropeginterferon Alfa-2B More therapies…

    Learn about Your Condition

    Endometriosis Respiratory tract infection Carpal tunnel syndrome Acute leukaemia Anal fissure Thromboembolectomy Neuralgia Hypertrophic cardiomyopathy Myelofibrosis Ocular melanoma Oral lichen planus Cataract Senile dementia Leukoencephalopathy Dent's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on [18F]Fluoro-PEG-Folate PET-CT Imaging to Monitor Therapy Response in Patients with Rheumatoid Arthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • [18F]Fluoro-Peg-Folate
    The Netherlands

  • Study on Botulinum Toxin Type A for Treating Spastic Equinovarus in First-Time Stroke Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Belgium

  • Study Comparing Infliximab and NSAID Drug Combination for Patients with Axial Spondyloarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Diclofenac Diethylamine
    • Etoricoxib
    • Ibuprofen Lysine
    Germany

  • Study Comparing Ulipristal Acetate and Surgery for Women with Symptomatic Uterine Fibroids

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uterine leiomyoma
    Investigated Drugs:
    • Ulipristal Acetate
    The Netherlands

  • Study on the Effects of Intracochlear Triamcinolone Acetonide for Patients with Persistent Sudden Sensorineural Hearing Loss After Unsuccessful Conservative Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Deafness
    • Deafness neurosensory
    Investigated Drugs:
    • Triamcinolone Acetonide
    Austria

  • Study of Digitoxin with Chemotherapy for Patients with Inoperable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Digitoxin
    Sweden
Previous Page
1 … 304 305 306 307 308 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!